retatrutide liver damage and fatty study Researchers report promising results with retatrutide, which significantly reduced fat in some patients over several months. Excess liver fat causes metabolic dysfunction–associated steatotic liver disease (MASLD Retatrutide Liver Fat Reduction: Evidence,

Shop N-Acetyl L-Carnitine R142,00 Cognitive and energy support for focus, mood, and cellular health

A New Maintenance Strategy After GLP Injections Oral GLP-1 maintenance after injectable weight loss Eli Lilly has reported positive topline Phase 3 results from ATTAIN-MAINTAIN, a trial designed to answer a very practical question: after achieving weight loss on injectable therapies, can patients maintain that loss by switching to a once-daily oral GLP-1

Achieving and maintaining a healthy weight can be challenging, even with consistent diet and exercise

The renal-impairment PK study NCT05611957 is the study that speaks directly to this page's subject